Company attributes
Industry
Location
B2X
Founder
Pitchbook URL
Legal Name
Passage Bio Inc.0
Legal classification
Number of Employees (Ranges)
11 – 50
Email Address
media@passagebio.com0
info@passagebio.com0
corporatedevelopment@passagebio.com0
patientservices@passagebio.com0
medinfo@passagebio.com0
investors@passagebio.com0
Phone Number
+126786603110
Full Address
One Commerce Square 2005 Market Street, 39th Floor Philadelphia, PA 191030
CIK Number
Place of Incorporation
Investors
IRS Number
822,729,7510
Founded Date
2018
Total Funding Amount (USD)
379,500,000
Latest Funding Round Date
January 21, 2021
Competitors
Stock Symbol
PASG0
Exchange
Board of Directors
CFO
Former CEO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
SIC Code
2,8360
Ticker Symbol
PASG0
Passage Bio develops genetics-based medicines, including a pipeline of adeno-associate virus delivered therapeutics for the treatment of rare monogenic central nervous systems disorders.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
